Feed Top Reports Pricing

⌘K

09:38:13·15d

ANALYSTRating

Takeda Pharma upgraded by Bernstein

TAK· Takeda Pharmaceutical Company Limited

Health Care

Original source

Companies

TAK
Takeda Pharmaceutical Company Limited
Health Care

Recent analyst ratings

Apr 8UpdateBernstein-
Jan 13UpdateMorgan Stanley-
Apr 2UpdateMorgan Stanley-
Mar 16UpdateBofA Securities$20.00
Jul 19UpdateCowen$24.00
Oct 7UpdateMorgan Stanley-

Related

INSIDER18d
SEC Form 3 filed by new insider Greenway Nicola Deidre Petal
INSIDER18d
SEC Form 3 filed by new insider Farajallah Awny Samaan Botros
INSIDER18d
SEC Form 3 filed by new insider Ibrahim Ramy Riad Ahmed
PR23d
Takeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
SEC25d
SEC Form 6-K filed by Takeda Pharmaceutical Company Limited
PR26d
Takeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
SEC29d
SEC Form 6-K filed by Takeda Pharmaceutical Company Limited
SEC30d
SEC Form 6-K filed by Takeda Pharmaceutical Company Limited

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022